Abstract:The process of epithelial-mesenchymal transition (EMT) is essential for the proliferation and metastasis of tumor cells. Our previous study demonstrated that the expression of gangliotetraosylceramide (Gg4) and the transcription of UDP-Gal: beta 1,3-galactosyltransferase-4 (beta 3GalT4), a gene which controls the expression of Gg4, are reduced during transforming growth factor (TGF)-beta-induced EMT in normal murine mammary gland (NMuMG) cells. The present study revealed that the transcription level of beta 3GalT4 in patients with breast cancer was decreased compared with healthy control subjects. However, the molecular basis underlying these effects remains to be elucidated. Analysis of the beta 3Ga1T4 promoter sequence revealed a putative Smad-binding element (SBE) of Smad4, which is a transcriptional factor in TGF beta responses and forms a complex with Smad3. To clarify the association between the Smad3/4 complex and the beta 3Ga1T4 gene during EMT in NMuMG cells, an electrophoretic mobility shift assay and a chromatin immunoprecipitation assay were performed. The Smad3/4 complex was found to bind directly to the SBE of the beta 3Ga1T4 promoter. Overexpression of Smad3 and Smad4 through stable transfection had no notable effect on cell phenotype, but did alter the expression of various EMT protein markers. Treatment with TGF beta reduced the expression of Gg4 and the mRNA levels of the beta 3Ga1T4 gene in Smad3- and Smad4-overexpressing cells compared with vector-transfected cells. Expression of the epithelial markers E-cadherin and beta-catenin decreased in parallel with the reduction in Gg4. These findings suggested that the activated Smad3/4 complex downregulated the expression of Gg4 and the)beta 3GalT4 gene through translocation into the nucleus and binding to the [beta GalT4 promoter.

Down-regulation of β1,4-galactosyltransferase gene expression by cell-cycle suppressor gene p16

Effect of P58gta on Β-1,4-galactosyltransferase 1 Activity and Cell-Cycle in Human Hepatocarcinoma Cells

Regulation of the Beta 1,4-Galactosyltransferase I Promoter by E2f1

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

Downregulation of Β1,4-Galactosyltransferase 1 Inhibits CDK11p58-mediated Apoptosis Induced by Cycloheximide

Direct Interaction Between Surface Β1,4-Galactosyltransferase 1 and Epidermal Growth Factor Receptor (EGFR) Inhibits EGFR Activation in Hepatocellular Carcinoma

Down-regulation of the Expression of Β1,4-Galactosyltransferase V Promotes Integrin Β1 Maturation

Constitutively Active PKB/Akt Inhibited Apoptosis and Down-Regulated Β1,4-Galactosyltransferase 1 in Hepatocarcinoma Cells

Involvement of β 1,4 galactosyltransferase 1 and Galβ 1→4GlcNAc groups in human hepatocarcinoma cell apoptosis

Regulation of the expression and activity of β1,4-galactosyltransferase I by focal adhesion kinase

The Mechanism about the Proliferation of Schwann Cells Affected by Β1,4-Galactosyltransferase-i

[ANGPTL4 Gene Silencing by Short-Hairpin RNA Inhibits the Migration of Human Colorectal Cancer Cell Line HT29].

Elevated β1,4-Galactosyltransferase I in Highly Metastatic Human Lung Cancer Cells: IDENTIFICATION OF E1AF AS IMPORTANT TRANSCRIPTION ACTIVATOR

In Vitro Tumor Suppression of p16INK4a

Cell Surface Beta 1,4-Galactosyltransferase 1 Promotes Apoptosis by Inhibiting Epidermal Growth Factor Receptor Pathway

Beta 1,4-Galactosyltransferase V Regulates Self-Renewal of Glioma-Initiating Cell

Downregulation of Β1,4-Galactosyltransferase 5 Improves Insulin Resistance by Promoting Adipocyte Commitment and Reducing Inflammation

Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase-4 gene expression by Smads during transforming growth factor β-induced epithelial-mesenchymal transition.

Suppression of guman gastric cancer cells by introduction of p16 gene.

The Synergistic Function of Long and Short Forms of Β4galt1 in P53-Mediated Drug Resistance in Bladder Cancer Cells.

Effects of Suppressing Glucose Transporter-1 by an Antisense Oligodeoxynucleotide on the Growth of Human Hepatocellular Carcinoma Cells